People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

Chris Cavallo & Daughter Cristina Cavallo Co Founder's of The Robin Foundation Walk for Lives The Robin Foundation The Robin ...

The results, which come on the heels of the FDA’s approval of J&J’s esketamine nasal spray Spravato as a monotherapy for ...

The FDA has approved the use of Spravato, an antidepressant nasal spray, as a standalone treatment for depression in the U.S. Sue Varma discusses why she supports the use of the drug and how it may ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

School nurses, teachers or other people trained and qualified would be authorized to administer the nasal spray to a student or staff member experiencing symptoms of an opioid overdose.

The U.S. Food and Drug Administration (FDA) approved the antidepressant nasal spray Spravato as a standalone treatment for depression in adults.

The NDA is supported by data from a clinical trial that compared the absorption and efficacy of the nasal treatment with oral and IV bumetanide in 68 healthy adults.

(HealthDay News) — The US Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an inadequate response to at ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...

An ear, nose and throat doctor explains why tipping your head back with a nosebleed could make things worse and what you ...